US FDA approves Mirum's drug for rare bone disorder
25/09/2026 19:57
US FDA approves Mirum's drug for rare bone disorder Sept 25 (Reuters) - The US Food and Drug Administration has approved Mirum Pharmaceuticals' MIRM.O drug to treat a rare bone disorder, the regulator said on Friday.
(Reporting by Kunal Das and Christy Santhosh in Bengaluru; Editing by Jonathan Ananda)
Recent news on Incyte
See all newsIncyte Corp reports results for the quarter ended September 30 - Earnings Summary
Incyte Q3 adjusted loss per share beats estimates
Revolution Medicines falls after Incyte posts competitive pancreatic cancer data
Factbox: Pharma sector doubles down on AI to slash costs, timelines
US RESEARCH ROUNDUP-Eli Lilly, Netflix, Zscaler